Bullish (BLSH) Q2 2026 Earnings Call Transcript

Bullish reported Q2 2026 total adjusted revenue of $92.6M (+62% YoY) and adjusted EBITDA of $29.5M (~32% margin), but posted a Q2 net loss of $(280.0)M versus net income of $108.3M in Q2 2025, reflecting a softer crypto trading backdrop. Management narrowed full-year 2026 SS&O guidance to $225M–$245M and maintained adjusted OpEx guidance of $225M–$230M, while confirming the Equiniti acquisition remains on track for a January 2027 close (antitrust clearances secured). Strategically, tokenized Bullish shares began trading on its regulated venue on Aug. 12, and management expects U.S. derivatives access in the next several months, potentially supported by an anticipated SEC “innovation exemption”.

Analysis

This print matters less for current crypto beta than for the company’s option value as regulated market infrastructure. The recurring-services mix is doing the heavy lifting, which means the stock can rerate even if spot volumes stay soft; that shifts BLSH from a pure trading proxy toward a tollbooth on issuer workflows, data, registry, and venue access. If issuer-sponsored tokenization gains even modest traction, the losers are the synthetic wrappers and any venue that lacks transfer-agent/issuer relationships; the winners are the regulated rails, market makers, and broker-dealers that can intermediate compliant flow.

The key near-term catalyst stack is unusually tight: October showcase, possible SEC innovation exemption, and earlier-than-expected U.S. derivatives access. That creates a 30-90 day setup where sentiment can outrun fundamentals, but the 6-18 month risk is execution drag: if issuer adoption stays in pilot mode, the market will stop capitalizing TAM and refocus on the fact that 2026 transaction revenue is still highly dependent on volatility. The thesis is falsified if the company fails to convert the current pipeline into named issuers by year-end, or if U.S. derivatives access slips beyond the next few months.

Contrarian view: consensus may be over-discounting how fast tokenization can re-price the stock, but also overestimating how much it helps 2026 earnings. The real upside is 2027+, and that requires a functioning distribution layer, not just regulatory rhetoric. The most durable read-through is for firms tied to issuer servicing and market plumbing; the weakest is for crypto-only venues whose economics still depend on volatility cycles. SOFI is a secondary beneficiary only insofar as tokenized/stablecoin distribution expands, but that is more strategic optionality than near-term EPS lift.

Key Decisions for Investors

• Go long BLSH on 5-10% post-earnings pullbacks over the next 1-3 sessions; thesis is rerating toward infrastructure optionality, with stop-loss if the stock gives back the post-call move and cannot hold above that level for a week.
• Pair trade: long BLSH / short COIN for 1-3 months to isolate tokenization and recurring-revenue optionality versus a cleaner spot-vol beta; thesis breaks if crypto volatility reaccelerates sharply and exchange transaction revenues re-rate the whole group upward.
• Buy BLSH Jan-2027 call spreads into the Oct. 27 showcase; use event-driven upside with defined risk, and exit if the SEC innovation-exemption catalyst is delayed or issuer announcements remain generic.
• Watch-list, not a trade yet: SOFI for a potential distribution/partner read-through. Only get constructive if management links tokenized or stablecoin products to measurable customer growth or margin expansion; absent that, it is narrative beta, not fundamentals.